Researchers at New York University Abu Dhabi (NYUAD) have developed Spheromatrix, a simple and low-cost technology that ...

In a university lab, an AI system generated millions of novel molecules to fight drug-resistant infections. And they're ...

Over the last four or five years, while teaching pharmacology to students during his graduate program at UC Santa Barbara, doctoral candidate Willus Fisher noted a persistent problem. “Every year, I ...

In this article, we will delve into how technology has impacted the drug industry, from drug trafficking to advancements in the pharmaceutical industry… Technology has been a game-changer in various ...

GLP-1 agonist drugs essentially mimic the hormone’s action. Quite a few have been developed, including semaglutide, tirzepatide, liraglutide, and exenatide, which have brand names like Ozempic, ...

The Company’s IPO price was set at 26.68 RMB per share, with an opening price of 58 RMB, representing a 117% increase over ...

Men and women react differently to different drugs. That may sound like a no-brainer, but for years researchers have mainly focused on male patients’ reactions to drugs in clinical trials, which has ...

The U.S. Food and Drug Administration (FDA) has issued draft guidance on its “Platform Technology Designation Program,” which aims to streamline drug development, manufacturing, and marketing ...

KAIST (President Kwang Hyung Lee) announced on the 16th that an advanced AI-based drug interaction prediction technology developed by the Distinguished Professor Sang Yup Lee's research team in the ...

Blockchain is a database of information shared across a network. They're known in cryptocurrency systems like Bitcoin. Blockchain technology has the potential to revolutionize the drug discovery ...

On today's episode of the 5 Things podcast: A bill became law late last year that could mean the end of testing drugs on animals eventually. It's called the FDA Modernization Act 2.0. The law has ...

A portable device that can instantly detect dangerous street drugs at extremely low concentrations has been developed at the University of Bath in the UK. The device, which is being trialled by ...